Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis

Lİ, Xiaohua; WANG, Liangliang; Huang, Chunyan; YANG, Xiaoguang

doi:10.4274/balkanmedj.galenos.2020.2019.9.31

Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis

Xiaohua Lİ, (Affiliated Hospital of Jiujiang University, Department of General Surgery, Jiangxi, China)

Liangliang WANG, (Affiliated Hospital of Jiujiang University, Department of Pathology, Jiangxi, China)

Xiaoguang YANG, (Affiliated Hospital of Jiujiang University, Department of Ultrasonic, Jiangxi, China)

Chunyan HUANG (Affiliated Hospital of Jiujiang University, Department of Hospitality, Jiangxi, China)

Balkan Medical Journal

1 0

Yıl: 2020 Cilt: 37 Sayı: 4 Sayfa Aralığı: 196 - 202 Metin Dili: İngilizce DOI: 10.4274/balkanmedj.galenos.2020.2019.9.31 İndeks Tarihi: 02-11-2020

Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis

Öz:

Background: Donor organs for liver transplantation may often havefatty liver disease, which confers a higher sensitivity to ischemia/reperfusion injury. At present, there is no effective treatment forthe condition. Evidence has suggested that metformin, the first-linemedication for diabetes, has protective effects against many disorders.However, the potential role of metformin in ischemia/reperfusioninjury in fatty liver disease remains unclear.Aims: To examine the effect of metformin treatment duringischemia/reperfusion injury in fatty liver and determine the possiblemechanisms.Study Design: Animal experimentation.Methods: Sprague-Dawley male rats were fed a high-fat diet (520kcal/100 g) for 14 weeks and then were subjected to the orthotopicautologous liver transplantation model. Sections of liver tissue werestained with hematoxylin and eosin to visualize the damage. Bloodand liver samples were used to analyze the related proteins andcomponents involved in the inflammatory signaling pathway.Results: We found that metformin significantly ameliorated theischemia/reperfusion injury of the fatty liver through a reduction inalanine aminotransferase/aspartate aminotransferase concentrationsin the serum and a decrease in dead cells, as shown by the terminaldeoxynucleotidyl transferase-mediated dUTP nick-end labeling assay(p<0.05). In addition, metformin significantly attenuated interleukin(IL)-6, IL-1β, and tumor necrosis factor-α production and increasedthe expression of active caspase-3 and Bax in the liver (p<0.05).Mechanistically, metformin suppressed the activation of toll-likereceptor 4 (TLR4)/NF-κB signaling (p<0.05), resulting in a decreasedinflammatory response and apoptosis.Conclusion: Our findings demonstrated that metformin attenuatedischemia/reperfusion injury in fatty liver disease via the TLR4/NF-κB axis, suggesting that metformin could have potential therapeuticapplications in ischemia/reperfusion injury associated with livertransplantation

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426-37.
2. Fitzpatrick E. Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. Proc Nutr Soc 2019;78:362-71.
3. Yang HJ, Tang LM, Zhou XJ, Qian J, Zhu J, Lu L, et al. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2015;14:619-25.
4. Ramsey HE, Da Silva CG, Longo CR, Csizmadia E, Studer P, Patel VI, et al. A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. Liver Transpl 2009;15:1613-21.
5. Li S, Fujino M, Takahara T, Li XK. Protective role of heme oxygenase-1 in fatty liver ischemia-reperfusion injury. Med Mol Morphol 2018;52:61-72.
6. Vilatoba M, Eckstein C, Bilbao G, Smyth CA, Jenkins S, Thompson JA, et al. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery 2005;138:342-51.
7. Shao Z, Jiao B, Liu T, Cheng Y, Liu H, Liu Y. TAK-242 treatment ameliorates liver ischemia/reperfusion injury by inhibiting TLR4 signaling pathway in a swine model of Maastricht-category-III cardiac death. Biomed Pharmacother 2016;84:495-501.
8. Pan H, Gu L, Liu B, Li Y, Wang Y, Bai X, et al. Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma. PLoS One 2017;12:e0168900.
9. Xu P, Zhang J, Wang H, Wang G, Wang CY, Zhang J. CCR2 dependent neutrophil activation and mobilization rely on TLR4-p38 axis during liver ischemia-reperfusion injury. Am J Transl Res 2017;9:2878-90.
10. Hui W, Jinxiang Z, Heshui W, Zhuoya L, Qichang Z. Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. Biochem Biophys Res Commun 2009;389:328-32.
11. Sherif IO, Al-Shaalan NH. Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-kB Signaling Pathway. Oxid Med Cell Longev 2018;2018:3509091.
12. Xie T, Li K, Gong X, Jiang R, Huang W, Chen X, et al. Paeoniflorin protects against liver ischemia/reperfusion injury in mice via inhibiting HMGB1-TLR4 signaling pathway. Phytother Res 2018;32:2247-55.
13. Shen XD, Ke B, Zhai Y, Gao F, Tsuchihashi S, Lassman CR, et al. Absence of tolllike receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model. Liver Transpl 2007;13:1435-43.
14. Zhai D, Zhang J, Zheng Q, Li Z, Zhang J, Tian Y. Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice. J Huazhong Univ Sci Technolog Med Sci 2008;28:564-7.
15. Liu CH, Hua N, Fu X, Pan YL, Li B, Li XD. Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats. BMC Cardiovasc Disord 2018;18:236.
16. Ashamalla M, Youssef I, Yacoub M, Jayarangaiah A, Gupta N, Ray J, et al. Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Antidiabetic Therapy. Glob J Obes Diabetes Metab Syndr 2018;5:8-14.
17. Tomic T, Botton T, Cerezo M, Robert G, Luciano F, Puissant A, et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis 2011;2:e199.
18. Abdellatif M, Sedej S, Carmona-Gutierrez D, Madeo F, Kroemer G. Autophagy in Cardiovascular Aging. Circ Res 2018;123:803-24.
19. Donnan K, Segar L. SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes. Eur J Pharmacol 2019;846:23-9.
20. Arnoux I, Willam M, Griesche N, Krummeich J, Watari H, Offermann N, et al. Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease. Elife 2018:7.
21. DiTacchio KA, Heinemann SF, Dziewczapolski G. Metformin treatment alters memory function in a mouse model of Alzheimer's disease. J Alzheimers Dis 2015;44:43-8.
22. Wang L, Xu JB, Wu HS, Zhang JX, Zhang JH, Tian Y, et al. The relationship between activation of TLR4 and partial hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2006;5:101-4.
23. Chen XX, Tang L, Han ZH, Wang WJ, Meng JG. Coculture with bone marrow-derived mesenchymal stem cells attenuates inflammation and apoptosis in lipopolysaccharidestimulated alveolar epithelial cells via enhanced secretion of keratinocyte growth factor and angiopoietin-1 modulating the Toll-like receptor-4 signal pathway. Mol Med Rep 2019;19:1891-902.
24. Gehrke N, Biedenbach J, Huber Y, Straub BK, Galle PR, Simon P, et al. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD. Sci Rep 2019;9:4007.
25. Xiao Z, Banan B, Xu M, Jia J, Manning PT, Hiebsch RR, et al. Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody. Transplantation 2016l;100:1480-9.
26. Satoh D, Yagi T, Nagasaka T, Shinoura S, Umeda Y, Yoshida R, et al. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy 2013;5:189-95.
27. Mohan R, Jose S, Sukumaran S, S A, S S, John G, I M K. Curcumin-galactomannosides mitigate alcohol-induced liver damage by inhibiting oxidative stress, hepatic inflammation, and enhance bioavailability on TLR4/MMP events compared to curcumin. J Biochem Mol Toxicol 2019:e22315.
28. Rex J, Lutz A, Faletti LE, Albrecht U, Thomas M, Bode JG, et al. IL-1β and TNFα Differentially Influence NF-κB Activity and FasL-Induced Apoptosis in Primary Murine Hepatocytes During LPS-Induced Inflammation. Front Physiol 2019;10:117.
29. Zheng D, Li Z, Wei X, Liu R, Shen A, He D, et al. Role of miR-148a in Mitigating Hepatic Ischemia-Reperfusion Injury by Repressing the TLR4 Signaling Pathway via Targeting CaMKIIalpha in Vivo and in Vitro. Cell Physiol Biochem 2018;49:2060-72.
30. Rao J, Qian X, Li G, Pan X, Zhang C, Zhang F, et al. ATF3-mediated NRF2/ HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/ reperfusion injury. Am J Transplant 2015;15:76-87.
31. McDonald KA, Huang H, Tohme S, Loughran P, Ferrero K, Billiar T, et al. Tolllike receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling. Mol Med 2015;20:639-48.
32. Jimenez-Castro MB, Elias-Miro M, Mendes-Braz M, Lemoine A, Rimola A, Rodes J, et al. Tauroursodeoxycholic acid affects PPARgamma and TLR4 in Steatotic liver transplantation. Am J Transplant 2012;12:3257-71.
33. Huang HF, Zeng Z, Wang KH, Zhang HY, Wang S, Zhou WX, et al. Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways. World J Gastroenterol 2015;21:2937-48.
34. Meguro M, Katsuramaki T, Kimura H, Isobe M, Nagayama M, Kukita K, et al. Apoptosis and necrosis after warm ischemia-reperfusion injury of the pig liver and their inhibition by ONO-1714. Transplantation 2003;75:703-10.
35. Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol 2013;3:977-1010.
36. Munoz-Casares FC, Padillo FJ, Briceno J, Collado JA, Munoz-Castaneda JR, Ortega R, et al. Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas. J Pineal Res 2006;40:195-203.
37. Crenesse D, Laurens M, Heurteaux C, Cursio R, Saint-Paul MC, Schmid-Alliana A, et al. Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment. Eur J Pharmacol 2003;473:177-84.
38. Altunkan A, Aydin O, Ozer Z, Colak T, Bilgin E, Oral U. Anti-apoptotic effect of succinyl gelatine in a liver ischaemia-reperfusion injury model (Bcl-2, Bax, Caspase 3)? Pharmacol Res 2002;45:485-9.

APA	Lİ X, WANG L, YANG X, Huang C (2020). Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. , 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
Chicago	Lİ Xiaohua,WANG Liangliang,YANG Xiaoguang,Huang Chunyan Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. (2020): 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
MLA	Lİ Xiaohua,WANG Liangliang,YANG Xiaoguang,Huang Chunyan Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. , 2020, ss.196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
AMA	Lİ X,WANG L,YANG X,Huang C Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. . 2020; 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
Vancouver	Lİ X,WANG L,YANG X,Huang C Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. . 2020; 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
IEEE	Lİ X,WANG L,YANG X,Huang C "Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis." , ss.196 - 202, 2020. 10.4274/balkanmedj.galenos.2020.2019.9.31
ISNAD	Lİ, Xiaohua vd. "Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis". (2020), 196-202. https://doi.org/10.4274/balkanmedj.galenos.2020.2019.9.31

APA	Lİ X, WANG L, YANG X, Huang C (2020). Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. Balkan Medical Journal, 37(4), 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
Chicago	Lİ Xiaohua,WANG Liangliang,YANG Xiaoguang,Huang Chunyan Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. Balkan Medical Journal 37, no.4 (2020): 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
MLA	Lİ Xiaohua,WANG Liangliang,YANG Xiaoguang,Huang Chunyan Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. Balkan Medical Journal, vol.37, no.4, 2020, ss.196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
AMA	Lİ X,WANG L,YANG X,Huang C Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. Balkan Medical Journal. 2020; 37(4): 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
Vancouver	Lİ X,WANG L,YANG X,Huang C Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. Balkan Medical Journal. 2020; 37(4): 196 - 202. 10.4274/balkanmedj.galenos.2020.2019.9.31
IEEE	Lİ X,WANG L,YANG X,Huang C "Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis." Balkan Medical Journal, 37, ss.196 - 202, 2020. 10.4274/balkanmedj.galenos.2020.2019.9.31
ISNAD	Lİ, Xiaohua vd. "Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis". Balkan Medical Journal 37/4 (2020), 196-202. https://doi.org/10.4274/balkanmedj.galenos.2020.2019.9.31